ciprofloxacin has been researched along with phenylalanine arginine beta-naphthylamide in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, A; Friederichs, S; Kehrenberg, C; Schwarz, S | 1 |
| Fanning, S; McCusker, M; O'Regan, E; Pagès, JM; Piddock, L; Quinn, T | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Deering, RW; Mincer, TJ; Poulson-Ellestad, KL; Rowley, DC; Whalen, KE | 1 |
| Allam, A; Alves de Sousa, R; Artaud, I; Dumont, E; Maigre, L; Pagès, JM; Vergalli, J | 1 |
| Jiminez de Anta, MT; Ribera, A; Ruiz, J; Vila, J | 1 |
| Coban, AY; Durupinar, B; Ekinci, B | 1 |
| Cebrián, L; Escribano, I; Rodríguez, JC; Royo, G | 1 |
| Cetinkaya, E; Coban, AY; Durupinar, B | 1 |
| Comets, E; Couet, W; Grégoire, N; Grignon, C; Marliat, M; Ploy, MC; Raherison, S | 1 |
| Glatz, K; Pászti, J; Tóth, A | 1 |
| Almofti, YA; Dai, M; Hao, H; Huang, L; Liu, Z; Sun, Y; Wang, Y; Yuan, Z | 1 |
| Izard, D; Mullié, C; Sonnet, P | 1 |
| Klančnik, A; Kurinčič, M; Smole Možina, S | 1 |
| Mavri, A; Smole Možina, S | 1 |
| Bowlin, TL; D'Souza, S; Houseweart, C; Kim, HS; Kwasny, SM; Nguyen, ST; Nikaido, H; Opperman, TJ; Peet, NP; Walker, GC | 1 |
| Ahdash, Z; Booth, PJ; Fais, C; Findlay, H; Grimsey, E; Konijnenberg, A; Lau, AM; Malloci, G; Piddock, LJV; Politis, A; Reading, E; Ricci, V; Ruggerone, P; Stone, J; Vargiu, AV; Wang-Kan, X | 1 |
| Kayış, U; Kaynak Onurdağ, F; Ökten, S | 1 |
18 other study(ies) available for ciprofloxacin and phenylalanine arginine beta-naphthylamide
| Article | Year |
|---|---|
Novel variant of the qnrB gene, qnrB12, in Citrobacter werkmanii.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Citrobacter; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests | 2008 |
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Salmonella enteritidis; Trans-Activators | 2009 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
Topics: Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple; Fluorescent Dyes; Gram-Negative Bacteria; Membrane Transport Proteins; Metabolomics; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudoalteromonas; Pseudomonas aeruginosa; Pyrroles | 2015 |
New amphiphilic neamine conjugates bearing a metal binding motif active against MDR E. aerogenes Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Cell Membrane Permeability; Cephalosporins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Escherichia coli; Framycetin; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Organometallic Compounds | 2017 |
Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates.
Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Reserpine | 2002 |
A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates.
Topics: Bacterial Outer Membrane Proteins; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2004 |
Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Salmonella; Salmonella Infections | 2005 |
[Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Topics: Acinetobacter baumannii; Anti-Infective Agents; Ciprofloxacin; Dipeptides; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Reserpine; Staphylococcus aureus | 2008 |
Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Dipeptides; Drug Resistance, Bacterial; Genes, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
The cyclohexane tolerance and Phe-Arg-β-naphtylamide susceptibility of multidrug-resistant Enterobacter cloacae clinical isolates, and the predominance of one PFGE clone in Hungary.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Cyclohexanes; Dipeptides; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Hungary; Polymerase Chain Reaction | 2011 |
The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.
Topics: Anti-Infective Agents; Bacterial Proteins; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutation; Nalidixic Acid; Promoter Regions, Genetic; Proton Ionophores; Reverse Transcriptase Polymerase Chain Reaction; Salmonella typhimurium; Trans-Activators | 2011 |
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Piperazine; Piperazines; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in Campylobacter spp. isolates.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter jejuni; Catechin; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperazines; Tetracycline Resistance | 2012 |
Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Deoxycholic Acid; Dipeptides; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Piperazines; Poultry; Swine | 2013 |
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Levofloxacin; Membrane Transport Modulators; Microbial Sensitivity Tests; Piperacillin; Pyrans; Pyridines | 2014 |
Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB.
Topics: Anti-Bacterial Agents; Binding Sites; Biological Transport, Active; Ciprofloxacin; Circular Dichroism; Deuterium; Dipeptides; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Ligands; Mass Spectrometry; Membrane Proteins; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Multidrug Resistance-Associated Proteins; Mutation; Protein Kinases | 2020 |
[Effect of Phenylalanine-arginine-beta-naphthylamide to Ciprofloxacin Minimum Inhibitory Concentration Values and Expression of Efflux Pump System Genes in Acinetobacter baumannii Isolates].
Topics: Acinetobacter baumannii; Arginine; Ciprofloxacin; Dipeptides; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Naphthalenes; Phenylalanine | 2021 |